proteomic changes upon treatment with semaglutide in individuals with obesity A Multidisciplinary Perspective on and Medical Nutrition Therapy Management | Current Obesity Reports Proteomic changes upon treatment with

FODMAPs are found in a variety of foods and can cause digestive symptoms such as bloating, gas, and stomach pain in people with certain digestive disorders, such as irritable bowel syndrome (IBS)

Extending the period of exclusivity, whether through new FDA-approved indications or through biologic designation, delays competition and maximizes profits for the company

What to know before considering adjunctive therapies Hirsch, Vieira, and Jervey emphasized that adjunctive therapies are not for everyone with type 1

A patient with Type 2 diabetes choosing between a GLP-1 and an older oral agent is no longer making a purely glycemic decision